Search

You searched for "diagnosis"

1568 results found

RSM: Advancements in Ophthalmology: Bridging Global Divides with AI, VR, and XR Technology

14 November 2024
This webinar will showcase cutting-edge technological advancements in ophthalmology and how these innovations are revolutionising healthcare delivery, particularly in the Global South. With a strong emphasis on Artificial Intelligence (AI), Virtual Reality (VR), and Extended Reality (XR), the meeting will...

Moorfields: Ophthalmic emergency study day Oct 25

4 October 2025
This study day aims to upskill ophthalmic practitioners in the triaging, assessment and management of emergency eye conditions.

Fluorescein angiography and OCT in myopic CNV

1 December 2014 | | EYE - Vitreo-Retinal
Fluorescein angiography (FA) and spectral-domain optical coherence tomography (OCT) are the most common examinations used in the management of anti-VEGF therapy in choroidal neovascularisation (CNV). In comparison to FA, OCT provides a noninvasive evaluation of the macula. Myopic CNV are...

Density of cataract and its influence on retinal nerve fibre layer thickness

1 December 2013 | | EYE - Vitreo-Retinal
The aim of this study was to further define and model the influence of cataract on spectral domain optical coherence tomography (SDOCT) image quality and retinal nerve fibre layer (RNFL) thickness measurements. OCT quality is influenced by opacities in the...

Lacquer cracks

1 August 2019 | | EYE - Vitreo-Retinal
The purpose of this Japanese study was to analyse the morphologic features and natural progression patterns of lacquer cracks (LC). The presence of linear hyperfluorescence on the fundus fluorescein angiography (FFA) was used as the standard for diagnosing the presence...
Neuro-Ophthalmology journal cover image

Current literature evidence for fulminant idiopathic intracranial hypertension

1 May 2025 | | EYE - Neuro-ophthalmology
Fulminant idiopathic intracranial hypertension (IIH) is a rapid vision-degrading presentation of IIH with limited published studies. This narrative review aims to collate current knowledge around fulminant IIH presentation and visual outcomes. Search terms included IIH, benign intracranial hypertension, or pseudo-tumour...

In conversation with Pearse Keane (2018)

1 March 2019 | EYE - Vitreo-Retinal, EYE - General
AI was a hot topic at the 18th Congress of the European Society of Retina Specialists (EURETINA), following the publication of important findings in relation to using this technology in diagnosing retinal disease. We were delighted to catch Pearse Keane,...

The lived experience of benign essential blepharospasm

4 December 2025 | | EYE - Oculoplastic
Benign essential blepharospasm (BEB) is a rare neurological condition which causes involuntary sustained or intermittent muscular contraction of both eyelids and upper facial muscles which cause closure of eyelids, abnormal facial expressions and distress [1]. The term dystonia is an...

Like a moth to AC flare: CMV-associated hypertensive anterior uveitis

19 September 2025 | | EYE - Glaucoma
Hypertensive anterior uveitis can present a diagnostic challenge to clinicians working in emergency eye departments. While prompt initial control of intraocular pressure (IOP) and inflammation is essential, elucidating the underlying aetiology is critical for long-term visual outcomes. When there is...

An eye on novel anti-cancer agents: an evidence-based approach to external eye assessment

5 April 2022 | | EYE - Cornea, EYE - General
Novel anti-cancer therapies have led to significant advancement in cancer treatment, however, they can be associated with external eye complications. It is important to be mindful of such adverse effects during assessment of patients enrolled in clinical trials. Annually, approximately...

My Top Five: Key insights from recent research into uveitis in adults

4 December 2025 | | EYE - Vitreo-Retinal
Uveitis, characterised by inflammation of the uvea – the eye’s middle layer comprising the iris, ciliary body, and choroid – remains a leading cause of visual impairment worldwide [1]. It primarily affects adults aged 20–50 years. Untreated uveitis may cause...